Last-Resort drug offered to teens with debilitating stomach paralysis
NCT ID NCT04699591
Summary
This program provides access to the drug domperidone for young people aged 12-21 who have severe gastroparesis (stomach paralysis) or GERD that hasn't improved with standard treatments. Participants take the medication four times daily and are closely monitored with regular heart checks and blood tests due to potential side effects. The goal is to control symptoms and improve quality of life for those who have no other treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Mercy Hospitals and Clinics
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.